Epigallocatechin gallate alleviates high-fat diet-induced hepatic lipotoxicity by targeting mitochondrial ROS-mediated ferroptosis
Background: Non-alcoholic fatty liver disease (NAFLD) is a chronic advanced liver disease that is highly related to metabolic disorders and induced by a high-fat diet (HFD). Recently, epigallocatechin gallate (EGCG) has been regarded as a protective bioactive polyphenol in green tea that has the abi...
Main Authors: | Shi-Bin Ding, Xiao-Lei Chu, Yu-Xuan Jin, Jin-Jin Jiang, Xiao Zhao, Min Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-03-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2023.1148814/full |
Similar Items
-
Epigallocatechin-3-Gallate Alleviates Liver Oxidative Damage Caused by Iron Overload in Mice through Inhibiting Ferroptosis
by: Chunjing Yang, et al.
Published: (2023-04-01) -
Epigallocatechin Gallate Attenuates Gentamicin-Induced Nephrotoxicity by Suppressing Apoptosis and Ferroptosis
by: Lin Yue, et al.
Published: (2022-12-01) -
Therapeutic effects of epigallocatechin and epigallocatechin gallate on the allergic reaction of αs1-casein sensitized mice
by: Qianqian Zhang, et al.
Published: (2023-05-01) -
Epigallocatechin gallate improves the quality of diabetic oocytes
by: Shuo Chao, et al.
Published: (2023-03-01) -
TLC separation of methylated (-)-epigallocatechin-3-gallate
by: Ryszard Amarowicz, et al.
Published: (2005-02-01)